Viral vectors are currently the most effective tools for in vivo gene transfer. Human adenovirus vectors (HAdV) derived from serotype 5 are the most characterized viruses among those of the same family. HAdV has been considered a good candidate for human gene therapy because of a number of advantages including its wide cell tropism in quiescent and non-quiescent cells, its inability to integrate the host genome and its high production titer.